See Remarks · Revolution Medicines, Inc. · Revolution Medicines, Inc. — Stock Option (Right to Buy)
Side
M
Value
—
Shares
9,363
Price
—
Executed
Sep 10, 2026
Disclosed
Sep 14, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Sep 10 executedSep 14, 2026 disclosed
RVMD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 10.7% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Revolution Medicines, Inc. — Stock Option (Right to Buy)
Ticker
RVMD
Shares
9,363
Price per share
$0
Execution date (reported)
Sep 10, 2026
Owned after transaction
96.7K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
4
What this establishes
Mancini Anthony filed this Form 4 reporting a option exercise of RVMD on Sep 10, 2026. It became public on Sep 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
See Remarks
Mancini Anthonycik:0002124509
Issuer
Revolution Medicines, Inc.cik:0001628171
Revision history · 0
No field has changed since this record was first ingested.
